Aehr Test Systems (AEHR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AEHR Annual Cash Flow →
From Aehr Test Systems through May 30 2025, changes in May 29 2026's operating cash flow provide insight into underlying business performance trends.
Quarterly Report, GAAP in USD millions
ITEM
(May 29 2026)
12 Months
(Feb 27 2026) (Nov 28 2025) (Aug 29 2025) (May 30 2025)
Operating Activities
Income-7.13
Depreciation & amortization4.30
Amortization of Other Assets1.20
Increase (Decrease) in Deferred Revenue3.21
Asset Impairment Charges0.01
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.01
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation6.76
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Income Tax Benefit Related To Dissolution Of Subsidiary-
Debt Instrument Decrease Forgiveness-
Gain From Forgiveness Of Ppp Loan-
Increase Decrease In Trade And Other Accounts Receivable-
Rent Adjustment And Amortization Of Lease Incentives-
Non Cash Operating Lease Expense-
Operating Lease Right Of Use Asset Amortization Expense0.54
Increase Decrease In Operating Lease Liabilities-
Increase Decrease In Operating Lease Liability-0.84
Income taxes0.00
Realized Investment Gains (Losses), Total0.00
Increase (Decrease) in Accounts Receivable3.31
Increase (Decrease) in Accounts Payable0.99
Increase (Decrease) in Accrued Liabilities1.02
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets2.76
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-19.73
Discontinued operations0.00
Net Cash flow from Operating Activities-3.31
Investing Activities
Capital Expenditures-2.07
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale and Maturity of Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-1.80
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-3.87
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock99.60
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-2.38
Other net0.00
Proceeds From Issuance Of Common Stock Under Private Placement-
Proceeds From Borrowing Repayments Of Lines Of Credit-
Proceeds From Issuance Of Follow On Public Offering Net Of Issuance Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents26.48
Sale Of Stock Number Of Shares Issued In Transaction-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities97.21
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-5.38
Total Cash Flow90.03
4 historic quarters locked

Sign in to unlock the full Aehr Test Systems cash flow history.

About Aehr Test Systems Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260227)
  • Filed with the SEC: April 8, 2026
  • Source: aehr_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001654954-26-003348

Figures are derived from filed reports and may be restated. Historical data is subject to revision.